Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss

Heterotopic ossification (HO) is the abnormal formation of bone in extraskeletal sites. However, the mechanisms linking HO pathogenesis with bone mass dysfunction remain unclear. Here, we showed that mice harboring injury-induced and BMP4-dependent HO exhibit bone mass loss similar to that presented...

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Chen, Yang, Jiazhao, Fan, Haitao, Dai, Yuanjuan, Wang, Xingxing, Chen, Rui, Liu, Jia, Meng, Xiangyue, Wang, Wei, Li, Guiling, Zhou, Jiao, Zhang, Ya, Zhu, Wanbo, Fang, Shiyuan, Wei, Haiming, Zheng, Hong, Wang, Siying, Ni, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605967/
https://www.ncbi.nlm.nih.gov/pubmed/36289197
http://dx.doi.org/10.1038/s41413-022-00232-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605967/
https://www.ncbi.nlm.nih.gov/pubmed/36289197
http://dx.doi.org/10.1038/s41413-022-00232-x

Ejemplares similares